CHROMITOPE SODIUM Drug Patent Profile
✉ Email this page to a colleague
When do Chromitope Sodium patents expire, and what generic alternatives are available?
Chromitope Sodium is a drug marketed by Bracco and is included in one NDA.
The generic ingredient in CHROMITOPE SODIUM is sodium chromate cr-51. There are one thousand four hundred and seventy-two drug master file entries for this compound. Additional details are available on the sodium chromate cr-51 profile page.
Summary for CHROMITOPE SODIUM
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 7 |
Patent Applications: | 56 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CHROMITOPE SODIUM at DailyMed |
US Patents and Regulatory Information for CHROMITOPE SODIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bracco | CHROMITOPE SODIUM | sodium chromate cr-51 | INJECTABLE;INJECTION | 013993-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Bracco | CHROMITOPE SODIUM | sodium chromate cr-51 | INJECTABLE;INJECTION | 013993-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |